Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A-Reference-Cited by-同舟云学术

Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A

Published:2011-03-28 Issue:6 Volume:17 Page:854-859
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

MARTINOWITZ U.,BJERRE J.,BRAND B.,KLAMROTH R.,MISGAV M.,MORFINI M.,SANTAGOSTINO E.,TIEDE A.,VIUFF D.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2011.02495.x/fullpdf

Reference20 articles.

1. Prophylaxis in people with haemophilia;Coppola;Thromb Haemost,2009

2. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia;Manco-Johnson;N Engl J Med,2007

3. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia;van den Berg;Br J Haematol,2001

4. Functional characteristics of N8, a new recombinant FVIII;Christiansen;Haemophilia,2010

5. Purification and characterization of a new recombinant factor VIII (N8);Thim;Haemophilia,2010

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-viral and viral delivery systems for hemophilia A therapy: recent development and prospects;Annals of Hematology;2023-11-11

2. Bioequivalence of recombinant factor VIII products: a position paper from the Italian Association of Hemophilia Centers;BLOOD TRANSFUS-ITALY;2023

3. Plasma Clearance of Coagulation Factor VIII and Extension of Its Half-Life for the Therapy of Hemophilia A: A Critical Review of the Current State of Research and Practice;International Journal of Molecular Sciences;2023-05-11

4. Perspective – The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021;Blood Reviews;2021-11

5. Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products;Research and Practice in Thrombosis and Haemostasis;2021-02